Abolish the DEA
The DEA's attempts to enforce the nation's drug laws have been a resounding failure by pretty much any measure.
The DEA's attempts to enforce the nation's drug laws have been a resounding failure by pretty much any measure.
Making DOI and DOC Schedule I drugs would interfere with psychiatric research.
At least he draws the right conclusion from this imaginary hazard, acknowledging the dangers created by prohibition.
While lawmakers remain resistant to change, most of the public thinks it's high time to stop treating marijuana as dangerous.
The presumptive Democratic nominee has a more liberal drug policy record than both the president and the Republican presidential nominee.
Recent footage shows a federal agent attempting to search a citizen’s bag without their consent, despite precedent saying that’s illegal.
The agency claims DOI and DOC have "a high potential for abuse" because they resemble other drugs it has placed in Schedule I.
As the DEA relentlessly tightens regulations on pain meds, the FDA refuses to approve a safer alternative already being used in similar countries.
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
Rescheduling does not resolve the conflict between federal pot prohibition and state rejection of that policy.
It looks like Attorney General Merrick Garland overrode the agency's recalcitrant drug warriors in deciding to reclassify the drug.
The vice president's exaggeration reflects a pattern of dishonesty in the administration's pitch to voters who oppose the war on weed.
Contrary to the president's rhetoric, moving marijuana to Schedule III will leave federal pot prohibition essentially unchanged.
For over 50 years, marijuana has been in the same category of controlled substances as heroin and LSD. The DEA is finally proposing to end that ludicrous policy.
Moving marijuana to Schedule III, as the DEA plans to do, leaves federal pot prohibition essentially untouched.
The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.
I'm the DEA's poster child for prescription stimulant abuse: a 30-something adult who needs a telehealth psychiatrist and can't remember what day the garbage truck comes.
The CDC’s numbers show that pain treatment is not responsible for escalating drug-related deaths.
The government still blames the private sector despite its own role in creating, exacerbating, and prolonging the shortage.
If drug warriors really wanted to punish "those responsible" for the transgender activist's death, they would start by arresting themselves.
Charlie Lynch’s ordeal is a vivid reminder of a senseless prohibition policy that persists thanks to political inertia.
Marijuana's classification has always been a political question, not a medical one.
The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.
The supposedly reformed drug warrior's intransigence on the issue complicates his appeal to young voters, who overwhelmingly favor legalization.
Under the Controlled Substances Act, the agency does not have the discretion to "deschedule marijuana altogether."
The points about marijuana's risks and benefits that the department now concedes were clear long before last August.
It appears that DEA agents have been employed on non-drug-related investigations for far longer than they were originally authorized.
Just as there are adult reasons for vape companies to sell flavored vape pods, there are adult reasons for drug dealers to color their fentanyl.
For five decades, drugs have been winning the war on drugs.
Research is promising, but drug warriors stand in the way.
The change, while welcome, is modest and won't get rid of patients' headaches as they try to fill their prescriptions.
The founder of MAPS talks about FDA approval for MDMA-assisted therapy and the "psychedelic renaissance" he has helped create.
The 1988 case highlighted the DEA's stubborn insistence that marijuana has no "accepted medical use."
Although the HHS-recommended change would benefit researchers and the cannabis industry, it would not resolve the conflict between state and federal marijuana laws.
"Airport purchase that could make you suspicious to the DEA"
Although it would leave federal prohibition essentially untouched, the change would facilitate medical research and dramatically reduce taxes on state-licensed suppliers.
Plus: Tennessee prosecutor threatens to use drag law that was declared unconstitutional, ACLU asks FTC to investigate Mastercard's adult content policy, and more...
While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.
For five decades, the agency has destroyed countless lives while targeting Americans for personal choices and peaceful transactions.
Plus: Senate Republicans spar over TikTok and free speech, Americans can't agree on how to cut spending, and more...
Each year, the DEA sets production limits for certain drugs, including some ingredients in common amphetamine pills like Adderall.
On Friday, the DEA unveiled a plan to restrict doctors' ability to prescribe controlled drugs over telehealth.
It is hard to find evidence of this "disturbing trend."
Thousands of local, state, and federal law-enforcers have access to sensitive financial data.
Making it easier for scientists to study marijuana is a far cry from the liberalization that most Americans want.
"Keep safe from COVID by following CDC advice to wear a mask."
Limiting the supply of a controlled substance does not remove demand. Users simply look elsewhere, including more unsavory sources.